|Articles|June 1, 2008

Bovell table 2

Table 2: Additional interventions required during follow-up.

SLT

ALT

2

0

5

10

17

7

14

15

10

1

1

0

49

33

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Latest CME